nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosentan—CYP2C9—Disulfiram—alcohol dependence	0.182	0.501	CbGbCtD
Bosentan—CYP3A4—Disulfiram—alcohol dependence	0.106	0.291	CbGbCtD
Bosentan—CYP3A4—Citalopram—alcohol dependence	0.0753	0.208	CbGbCtD
Bosentan—ABCB11—bile—alcohol dependence	0.0265	0.34	CbGeAlD
Bosentan—EDNRB—adrenal cortex—alcohol dependence	0.00473	0.0607	CbGeAlD
Bosentan—EDNRB—pancreas—alcohol dependence	0.0042	0.0539	CbGeAlD
Bosentan—EDNRA—adrenal cortex—alcohol dependence	0.00391	0.0502	CbGeAlD
Bosentan—EDNRB—midbrain—alcohol dependence	0.00337	0.0433	CbGeAlD
Bosentan—ABCB11—digestive system—alcohol dependence	0.00289	0.0371	CbGeAlD
Bosentan—EDNRB—testis—alcohol dependence	0.00282	0.0362	CbGeAlD
Bosentan—EDNRA—midbrain—alcohol dependence	0.00279	0.0358	CbGeAlD
Bosentan—EDNRB—liver—alcohol dependence	0.00267	0.0343	CbGeAlD
Bosentan—EDNRB—cerebellum—alcohol dependence	0.00261	0.0335	CbGeAlD
Bosentan—ABCB11—endocrine gland—alcohol dependence	0.00239	0.0307	CbGeAlD
Bosentan—EDNRA—testis—alcohol dependence	0.00233	0.03	CbGeAlD
Bosentan—ABCB11—testis—alcohol dependence	0.00228	0.0293	CbGeAlD
Bosentan—ABCB11—liver—alcohol dependence	0.00216	0.0277	CbGeAlD
Bosentan—EDNRB—brain—alcohol dependence	0.00212	0.0272	CbGeAlD
Bosentan—EDNRA—brain—alcohol dependence	0.00175	0.0225	CbGeAlD
Bosentan—CYP2C9—cardiovascular system—alcohol dependence	0.00118	0.0152	CbGeAlD
Bosentan—CYP2C9—digestive system—alcohol dependence	0.00098	0.0126	CbGeAlD
Bosentan—CYP2C9—blood—alcohol dependence	0.000934	0.012	CbGeAlD
Bosentan—Hypoaesthesia—Acamprosate—alcohol dependence	0.000877	0.00239	CcSEcCtD
Bosentan—Epistaxis—Naltrexone—alcohol dependence	0.000876	0.00239	CcSEcCtD
Bosentan—Sinusitis—Naltrexone—alcohol dependence	0.000872	0.00238	CcSEcCtD
Bosentan—Oedema peripheral—Acamprosate—alcohol dependence	0.000868	0.00237	CcSEcCtD
Bosentan—Gastroenteritis—Citalopram—alcohol dependence	0.000862	0.00235	CcSEcCtD
Bosentan—Hepatic failure—Citalopram—alcohol dependence	0.00085	0.00232	CcSEcCtD
Bosentan—Eczema—Citalopram—alcohol dependence	0.00085	0.00232	CcSEcCtD
Bosentan—Dizziness—Disulfiram—alcohol dependence	0.000841	0.00229	CcSEcCtD
Bosentan—Nasal congestion—Citalopram—alcohol dependence	0.000838	0.00229	CcSEcCtD
Bosentan—Hepatitis—Naltrexone—alcohol dependence	0.000834	0.00228	CcSEcCtD
Bosentan—Tinnitus—Acamprosate—alcohol dependence	0.000822	0.00224	CcSEcCtD
Bosentan—CYP2C9—endocrine gland—alcohol dependence	0.00081	0.0104	CbGeAlD
Bosentan—Atrial fibrillation—Citalopram—alcohol dependence	0.000806	0.0022	CcSEcCtD
Bosentan—Thirst—Citalopram—alcohol dependence	0.000803	0.00219	CcSEcCtD
Bosentan—Rash—Disulfiram—alcohol dependence	0.000802	0.00219	CcSEcCtD
Bosentan—Headache—Disulfiram—alcohol dependence	0.000796	0.00217	CcSEcCtD
Bosentan—Immune system disorder—Acamprosate—alcohol dependence	0.000796	0.00217	CcSEcCtD
Bosentan—Chills—Acamprosate—alcohol dependence	0.000791	0.00216	CcSEcCtD
Bosentan—Hypoglycaemia—Citalopram—alcohol dependence	0.000783	0.00214	CcSEcCtD
Bosentan—Cardiac failure—Citalopram—alcohol dependence	0.000783	0.00214	CcSEcCtD
Bosentan—Lethargy—Citalopram—alcohol dependence	0.000779	0.00213	CcSEcCtD
Bosentan—Cerebrovascular accident—Citalopram—alcohol dependence	0.000779	0.00213	CcSEcCtD
Bosentan—Eye disorder—Naltrexone—alcohol dependence	0.000779	0.00213	CcSEcCtD
Bosentan—Tinnitus—Naltrexone—alcohol dependence	0.000778	0.00212	CcSEcCtD
Bosentan—Cardiac disorder—Naltrexone—alcohol dependence	0.000774	0.00211	CcSEcCtD
Bosentan—Mental disorder—Acamprosate—alcohol dependence	0.000772	0.00211	CcSEcCtD
Bosentan—Malnutrition—Acamprosate—alcohol dependence	0.000767	0.00209	CcSEcCtD
Bosentan—Hyponatraemia—Citalopram—alcohol dependence	0.000767	0.00209	CcSEcCtD
Bosentan—Pain in extremity—Citalopram—alcohol dependence	0.000764	0.00208	CcSEcCtD
Bosentan—Disturbance in sexual arousal—Citalopram—alcohol dependence	0.000758	0.00207	CcSEcCtD
Bosentan—Angiopathy—Naltrexone—alcohol dependence	0.000757	0.00206	CcSEcCtD
Bosentan—Flatulence—Acamprosate—alcohol dependence	0.000756	0.00206	CcSEcCtD
Bosentan—Immune system disorder—Naltrexone—alcohol dependence	0.000753	0.00206	CcSEcCtD
Bosentan—Affect lability—Citalopram—alcohol dependence	0.000752	0.00205	CcSEcCtD
Bosentan—Mediastinal disorder—Naltrexone—alcohol dependence	0.000752	0.00205	CcSEcCtD
Bosentan—Chills—Naltrexone—alcohol dependence	0.000748	0.00204	CcSEcCtD
Bosentan—CYP3A4—digestive system—alcohol dependence	0.000747	0.00959	CbGeAlD
Bosentan—Back pain—Acamprosate—alcohol dependence	0.000742	0.00203	CcSEcCtD
Bosentan—Muscle spasms—Acamprosate—alcohol dependence	0.000738	0.00201	CcSEcCtD
Bosentan—Mental disorder—Naltrexone—alcohol dependence	0.000731	0.00199	CcSEcCtD
Bosentan—CYP2C9—liver—alcohol dependence	0.00073	0.00937	CbGeAlD
Bosentan—Irritability—Citalopram—alcohol dependence	0.000729	0.00199	CcSEcCtD
Bosentan—Cardiac arrest—Citalopram—alcohol dependence	0.000726	0.00198	CcSEcCtD
Bosentan—Malnutrition—Naltrexone—alcohol dependence	0.000726	0.00198	CcSEcCtD
Bosentan—Mood swings—Citalopram—alcohol dependence	0.000724	0.00197	CcSEcCtD
Bosentan—Tremor—Acamprosate—alcohol dependence	0.000719	0.00196	CcSEcCtD
Bosentan—Flatulence—Naltrexone—alcohol dependence	0.000715	0.00195	CcSEcCtD
Bosentan—CYP3A4—blood—alcohol dependence	0.000712	0.00914	CbGeAlD
Bosentan—Dehydration—Citalopram—alcohol dependence	0.00071	0.00194	CcSEcCtD
Bosentan—Anaemia—Acamprosate—alcohol dependence	0.000709	0.00194	CcSEcCtD
Bosentan—Liver function test abnormal—Citalopram—alcohol dependence	0.000705	0.00192	CcSEcCtD
Bosentan—Back pain—Naltrexone—alcohol dependence	0.000702	0.00192	CcSEcCtD
Bosentan—Angioedema—Acamprosate—alcohol dependence	0.000701	0.00191	CcSEcCtD
Bosentan—Dry skin—Citalopram—alcohol dependence	0.0007	0.00191	CcSEcCtD
Bosentan—Muscle spasms—Naltrexone—alcohol dependence	0.000698	0.0019	CcSEcCtD
Bosentan—Orthostatic hypotension—Citalopram—alcohol dependence	0.000698	0.0019	CcSEcCtD
Bosentan—Abdominal pain upper—Citalopram—alcohol dependence	0.000698	0.0019	CcSEcCtD
Bosentan—Hypokalaemia—Citalopram—alcohol dependence	0.000695	0.0019	CcSEcCtD
Bosentan—Vertigo—Acamprosate—alcohol dependence	0.000689	0.00188	CcSEcCtD
Bosentan—Syncope—Acamprosate—alcohol dependence	0.000688	0.00188	CcSEcCtD
Bosentan—Cramp muscle—Citalopram—alcohol dependence	0.000688	0.00188	CcSEcCtD
Bosentan—Leukopenia—Acamprosate—alcohol dependence	0.000687	0.00187	CcSEcCtD
Bosentan—Vision blurred—Naltrexone—alcohol dependence	0.000684	0.00187	CcSEcCtD
Bosentan—Nasopharyngitis—Citalopram—alcohol dependence	0.000683	0.00186	CcSEcCtD
Bosentan—Tremor—Naltrexone—alcohol dependence	0.00068	0.00186	CcSEcCtD
Bosentan—Palpitations—Acamprosate—alcohol dependence	0.000678	0.00185	CcSEcCtD
Bosentan—Loss of consciousness—Acamprosate—alcohol dependence	0.000674	0.00184	CcSEcCtD
Bosentan—Cough—Acamprosate—alcohol dependence	0.00067	0.00183	CcSEcCtD
Bosentan—Abdominal distension—Citalopram—alcohol dependence	0.000665	0.00181	CcSEcCtD
Bosentan—Angioedema—Naltrexone—alcohol dependence	0.000663	0.00181	CcSEcCtD
Bosentan—Influenza—Citalopram—alcohol dependence	0.00066	0.0018	CcSEcCtD
Bosentan—Asthma—Citalopram—alcohol dependence	0.00066	0.0018	CcSEcCtD
Bosentan—Eosinophilia—Citalopram—alcohol dependence	0.000654	0.00178	CcSEcCtD
Bosentan—Arthralgia—Acamprosate—alcohol dependence	0.000653	0.00178	CcSEcCtD
Bosentan—Chest pain—Acamprosate—alcohol dependence	0.000653	0.00178	CcSEcCtD
Bosentan—Syncope—Naltrexone—alcohol dependence	0.000651	0.00178	CcSEcCtD
Bosentan—Anxiety—Acamprosate—alcohol dependence	0.000651	0.00178	CcSEcCtD
Bosentan—Bronchospasm—Citalopram—alcohol dependence	0.000649	0.00177	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.000649	0.00177	CcSEcCtD
Bosentan—Discomfort—Acamprosate—alcohol dependence	0.000645	0.00176	CcSEcCtD
Bosentan—Angina pectoris—Citalopram—alcohol dependence	0.000643	0.00175	CcSEcCtD
Bosentan—Sweating increased—Citalopram—alcohol dependence	0.000643	0.00175	CcSEcCtD
Bosentan—Palpitations—Naltrexone—alcohol dependence	0.000642	0.00175	CcSEcCtD
Bosentan—Dry mouth—Acamprosate—alcohol dependence	0.000639	0.00174	CcSEcCtD
Bosentan—Loss of consciousness—Naltrexone—alcohol dependence	0.000638	0.00174	CcSEcCtD
Bosentan—Bronchitis—Citalopram—alcohol dependence	0.000635	0.00173	CcSEcCtD
Bosentan—Cough—Naltrexone—alcohol dependence	0.000633	0.00173	CcSEcCtD
Bosentan—Anaphylactic shock—Acamprosate—alcohol dependence	0.000626	0.00171	CcSEcCtD
Bosentan—CYP3A4—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000625	0.00323	CbGpPWpGaD
Bosentan—Infection—Acamprosate—alcohol dependence	0.000622	0.0017	CcSEcCtD
Bosentan—CYP3A4—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.000621	0.00322	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—NPY—alcohol dependence	0.000618	0.0032	CbGpPWpGaD
Bosentan—Chest pain—Naltrexone—alcohol dependence	0.000618	0.00169	CcSEcCtD
Bosentan—Arthralgia—Naltrexone—alcohol dependence	0.000618	0.00169	CcSEcCtD
Bosentan—CYP3A4—endocrine gland—alcohol dependence	0.000618	0.00793	CbGeAlD
Bosentan—Dysuria—Citalopram—alcohol dependence	0.000617	0.00168	CcSEcCtD
Bosentan—EDNRA—G alpha (q) signalling events—AVP—alcohol dependence	0.000617	0.00319	CbGpPWpGaD
Bosentan—Shock—Acamprosate—alcohol dependence	0.000616	0.00168	CcSEcCtD
Bosentan—Anxiety—Naltrexone—alcohol dependence	0.000616	0.00168	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.000614	0.00168	CcSEcCtD
Bosentan—Upper respiratory tract infection—Citalopram—alcohol dependence	0.000614	0.00167	CcSEcCtD
Bosentan—Thrombocytopenia—Acamprosate—alcohol dependence	0.000613	0.00167	CcSEcCtD
Bosentan—CYP3A4—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000612	0.00317	CbGpPWpGaD
Bosentan—Tachycardia—Acamprosate—alcohol dependence	0.000611	0.00167	CcSEcCtD
Bosentan—Discomfort—Naltrexone—alcohol dependence	0.000611	0.00167	CcSEcCtD
Bosentan—Pollakiuria—Citalopram—alcohol dependence	0.00061	0.00166	CcSEcCtD
Bosentan—EDNRA—Peptide ligand-binding receptors—AVP—alcohol dependence	0.000609	0.00315	CbGpPWpGaD
Bosentan—EDNRA—GPCRs, Class A Rhodopsin-like—DRD4—alcohol dependence	0.000608	0.00315	CbGpPWpGaD
Bosentan—Skin disorder—Acamprosate—alcohol dependence	0.000608	0.00166	CcSEcCtD
Bosentan—Hyperhidrosis—Acamprosate—alcohol dependence	0.000605	0.00165	CcSEcCtD
Bosentan—Dry mouth—Naltrexone—alcohol dependence	0.000604	0.00165	CcSEcCtD
Bosentan—Weight increased—Citalopram—alcohol dependence	0.000601	0.00164	CcSEcCtD
Bosentan—Weight decreased—Citalopram—alcohol dependence	0.000597	0.00163	CcSEcCtD
Bosentan—Anorexia—Acamprosate—alcohol dependence	0.000597	0.00163	CcSEcCtD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—HTR1B—alcohol dependence	0.000596	0.00309	CbGpPWpGaD
Bosentan—Hyperglycaemia—Citalopram—alcohol dependence	0.000595	0.00163	CcSEcCtD
Bosentan—CYP2C9—Biological oxidations—ADH6—alcohol dependence	0.000595	0.00308	CbGpPWpGaD
Bosentan—Anaphylactic shock—Naltrexone—alcohol dependence	0.000592	0.00162	CcSEcCtD
Bosentan—Oedema—Naltrexone—alcohol dependence	0.000592	0.00162	CcSEcCtD
Bosentan—EDNRA—GPCR ligand binding—CRHR1—alcohol dependence	0.000592	0.00307	CbGpPWpGaD
Bosentan—Pneumonia—Citalopram—alcohol dependence	0.000592	0.00162	CcSEcCtD
Bosentan—Infection—Naltrexone—alcohol dependence	0.000589	0.00161	CcSEcCtD
Bosentan—CYP2C9—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000589	0.00305	CbGpPWpGaD
Bosentan—Infestation NOS—Citalopram—alcohol dependence	0.000589	0.00161	CcSEcCtD
Bosentan—Infestation—Citalopram—alcohol dependence	0.000589	0.00161	CcSEcCtD
Bosentan—Hypotension—Acamprosate—alcohol dependence	0.000585	0.0016	CcSEcCtD
Bosentan—Stevens-Johnson syndrome—Citalopram—alcohol dependence	0.000584	0.00159	CcSEcCtD
Bosentan—Shock—Naltrexone—alcohol dependence	0.000583	0.00159	CcSEcCtD
Bosentan—Nervous system disorder—Naltrexone—alcohol dependence	0.000581	0.00159	CcSEcCtD
Bosentan—EDNRA—GPCRs, Class A Rhodopsin-like—CNR1—alcohol dependence	0.000581	0.00301	CbGpPWpGaD
Bosentan—Acute coronary syndrome—Citalopram—alcohol dependence	0.00058	0.00158	CcSEcCtD
Bosentan—Tachycardia—Naltrexone—alcohol dependence	0.000578	0.00158	CcSEcCtD
Bosentan—CYP3A4—nervous system—alcohol dependence	0.000578	0.00742	CbGeAlD
Bosentan—Myocardial infarction—Citalopram—alcohol dependence	0.000577	0.00157	CcSEcCtD
Bosentan—Skin disorder—Naltrexone—alcohol dependence	0.000575	0.00157	CcSEcCtD
Bosentan—Stomatitis—Citalopram—alcohol dependence	0.000574	0.00157	CcSEcCtD
Bosentan—Jaundice—Citalopram—alcohol dependence	0.000574	0.00157	CcSEcCtD
Bosentan—Hyperhidrosis—Naltrexone—alcohol dependence	0.000573	0.00156	CcSEcCtD
Bosentan—Urinary tract infection—Citalopram—alcohol dependence	0.000572	0.00156	CcSEcCtD
Bosentan—Conjunctivitis—Citalopram—alcohol dependence	0.000572	0.00156	CcSEcCtD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—AVP—alcohol dependence	0.000571	0.00296	CbGpPWpGaD
Bosentan—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.000571	0.00156	CcSEcCtD
Bosentan—EDNRA—GPCRs, Class A Rhodopsin-like—HTR7—alcohol dependence	0.000567	0.00293	CbGpPWpGaD
Bosentan—EDNRA—GPCRs, Class A Rhodopsin-like—DRD2—alcohol dependence	0.000567	0.00293	CbGpPWpGaD
Bosentan—Insomnia—Acamprosate—alcohol dependence	0.000566	0.00155	CcSEcCtD
Bosentan—EDNRB—Peptide ligand-binding receptors—POMC—alcohol dependence	0.000566	0.00293	CbGpPWpGaD
Bosentan—Anorexia—Naltrexone—alcohol dependence	0.000565	0.00154	CcSEcCtD
Bosentan—Paraesthesia—Acamprosate—alcohol dependence	0.000562	0.00153	CcSEcCtD
Bosentan—Haematuria—Citalopram—alcohol dependence	0.000561	0.00153	CcSEcCtD
Bosentan—EDNRA—GPCR downstream signaling—OPRK1—alcohol dependence	0.000559	0.00289	CbGpPWpGaD
Bosentan—Dyspnoea—Acamprosate—alcohol dependence	0.000558	0.00152	CcSEcCtD
Bosentan—EDNRA—GPCR ligand binding—CHRM2—alcohol dependence	0.000557	0.00288	CbGpPWpGaD
Bosentan—CYP3A4—liver—alcohol dependence	0.000557	0.00715	CbGeAlD
Bosentan—Somnolence—Acamprosate—alcohol dependence	0.000557	0.00152	CcSEcCtD
Bosentan—Hepatobiliary disease—Citalopram—alcohol dependence	0.000557	0.00152	CcSEcCtD
Bosentan—CYP3A4—central nervous system—alcohol dependence	0.000557	0.00714	CbGeAlD
Bosentan—Epistaxis—Citalopram—alcohol dependence	0.000555	0.00152	CcSEcCtD
Bosentan—EDNRB—GPCRs, Class A Rhodopsin-like—HTR2A—alcohol dependence	0.000555	0.00287	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—DRD4—alcohol dependence	0.000555	0.00287	CbGpPWpGaD
Bosentan—Sinusitis—Citalopram—alcohol dependence	0.000552	0.00151	CcSEcCtD
Bosentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—alcohol dependence	0.000552	0.00286	CbGpPWpGaD
Bosentan—Dyspepsia—Acamprosate—alcohol dependence	0.000551	0.0015	CcSEcCtD
Bosentan—Decreased appetite—Acamprosate—alcohol dependence	0.000544	0.00149	CcSEcCtD
Bosentan—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000541	0.00148	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.00054	0.00147	CcSEcCtD
Bosentan—Bradycardia—Citalopram—alcohol dependence	0.000538	0.00147	CcSEcCtD
Bosentan—Insomnia—Naltrexone—alcohol dependence	0.000536	0.00146	CcSEcCtD
Bosentan—Constipation—Acamprosate—alcohol dependence	0.000535	0.00146	CcSEcCtD
Bosentan—Pain—Acamprosate—alcohol dependence	0.000535	0.00146	CcSEcCtD
Bosentan—Paraesthesia—Naltrexone—alcohol dependence	0.000532	0.00145	CcSEcCtD
Bosentan—Haemoglobin—Citalopram—alcohol dependence	0.000531	0.00145	CcSEcCtD
Bosentan—EDNRB—GPCR ligand binding—CNR1—alcohol dependence	0.00053	0.00274	CbGpPWpGaD
Bosentan—Haemorrhage—Citalopram—alcohol dependence	0.000528	0.00144	CcSEcCtD
Bosentan—Hepatitis—Citalopram—alcohol dependence	0.000528	0.00144	CcSEcCtD
Bosentan—Dyspnoea—Naltrexone—alcohol dependence	0.000528	0.00144	CcSEcCtD
Bosentan—Somnolence—Naltrexone—alcohol dependence	0.000527	0.00144	CcSEcCtD
Bosentan—Hypoaesthesia—Citalopram—alcohol dependence	0.000526	0.00143	CcSEcCtD
Bosentan—EDNRB—GPCR downstream signaling—OPRD1—alcohol dependence	0.000525	0.00272	CbGpPWpGaD
Bosentan—Urinary tract disorder—Citalopram—alcohol dependence	0.000522	0.00142	CcSEcCtD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—DRD4—alcohol dependence	0.000521	0.0027	CbGpPWpGaD
Bosentan—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000521	0.0027	CbGpPWpGaD
Bosentan—Oedema peripheral—Citalopram—alcohol dependence	0.000521	0.00142	CcSEcCtD
Bosentan—Urethral disorder—Citalopram—alcohol dependence	0.000518	0.00141	CcSEcCtD
Bosentan—EDNRB—GPCR ligand binding—DRD2—alcohol dependence	0.000517	0.00267	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—HTR7—alcohol dependence	0.000517	0.00267	CbGpPWpGaD
Bosentan—Decreased appetite—Naltrexone—alcohol dependence	0.000515	0.00141	CcSEcCtD
Bosentan—EDNRA—G alpha (q) signalling events—HTR2A—alcohol dependence	0.000513	0.00266	CbGpPWpGaD
Bosentan—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000512	0.0014	CcSEcCtD
Bosentan—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000511	0.0014	CcSEcCtD
Bosentan—EDNRA—GPCR ligand binding—OPRM1—alcohol dependence	0.000511	0.00265	CbGpPWpGaD
Bosentan—Fatigue—Naltrexone—alcohol dependence	0.000511	0.00139	CcSEcCtD
Bosentan—EDNRA—Signaling by GPCR—OPRK1—alcohol dependence	0.000508	0.00263	CbGpPWpGaD
Bosentan—Pain—Naltrexone—alcohol dependence	0.000507	0.00138	CcSEcCtD
Bosentan—Constipation—Naltrexone—alcohol dependence	0.000507	0.00138	CcSEcCtD
Bosentan—EDNRB—GPCR downstream signaling—PDYN—alcohol dependence	0.000503	0.00261	CbGpPWpGaD
Bosentan—Erythema multiforme—Citalopram—alcohol dependence	0.0005	0.00136	CcSEcCtD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CNR1—alcohol dependence	0.000498	0.00258	CbGpPWpGaD
Bosentan—Urticaria—Acamprosate—alcohol dependence	0.000497	0.00136	CcSEcCtD
Bosentan—Body temperature increased—Acamprosate—alcohol dependence	0.000495	0.00135	CcSEcCtD
Bosentan—Abdominal pain—Acamprosate—alcohol dependence	0.000495	0.00135	CcSEcCtD
Bosentan—Eye disorder—Citalopram—alcohol dependence	0.000494	0.00135	CcSEcCtD
Bosentan—CYP2C9—Biological oxidations—ADH1A—alcohol dependence	0.000493	0.00255	CbGpPWpGaD
Bosentan—Tinnitus—Citalopram—alcohol dependence	0.000493	0.00134	CcSEcCtD
Bosentan—CYP3A4—Tryptophan metabolism—MAOB—alcohol dependence	0.000491	0.00254	CbGpPWpGaD
Bosentan—Cardiac disorder—Citalopram—alcohol dependence	0.00049	0.00134	CcSEcCtD
Bosentan—Flushing—Citalopram—alcohol dependence	0.00049	0.00134	CcSEcCtD
Bosentan—CYP2C9—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000488	0.00252	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—DRD2—alcohol dependence	0.000486	0.00251	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—HTR7—alcohol dependence	0.000486	0.00251	CbGpPWpGaD
Bosentan—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000484	0.00132	CcSEcCtD
Bosentan—Angiopathy—Citalopram—alcohol dependence	0.000479	0.00131	CcSEcCtD
Bosentan—Immune system disorder—Citalopram—alcohol dependence	0.000477	0.0013	CcSEcCtD
Bosentan—EDNRB—Signaling by GPCR—OPRD1—alcohol dependence	0.000477	0.00247	CbGpPWpGaD
Bosentan—Mediastinal disorder—Citalopram—alcohol dependence	0.000476	0.0013	CcSEcCtD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	0.000475	0.00246	CbGpPWpGaD
Bosentan—Chills—Citalopram—alcohol dependence	0.000474	0.00129	CcSEcCtD
Bosentan—Urticaria—Naltrexone—alcohol dependence	0.000471	0.00128	CcSEcCtD
Bosentan—EDNRA—GPCR ligand binding—NPY—alcohol dependence	0.000471	0.00244	CbGpPWpGaD
Bosentan—Abdominal pain—Naltrexone—alcohol dependence	0.000468	0.00128	CcSEcCtD
Bosentan—Body temperature increased—Naltrexone—alcohol dependence	0.000468	0.00128	CcSEcCtD
Bosentan—EDNRB—GPCR downstream signaling—CRHR1—alcohol dependence	0.000468	0.00242	CbGpPWpGaD
Bosentan—Mental disorder—Citalopram—alcohol dependence	0.000463	0.00126	CcSEcCtD
Bosentan—Hypersensitivity—Acamprosate—alcohol dependence	0.000461	0.00126	CcSEcCtD
Bosentan—Malnutrition—Citalopram—alcohol dependence	0.00046	0.00126	CcSEcCtD
Bosentan—Erythema—Citalopram—alcohol dependence	0.00046	0.00126	CcSEcCtD
Bosentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—alcohol dependence	0.000459	0.00238	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—PDYN—alcohol dependence	0.000457	0.00237	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—CRH—alcohol dependence	0.000454	0.00235	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—HTR1B—alcohol dependence	0.000454	0.00235	CbGpPWpGaD
Bosentan—Flatulence—Citalopram—alcohol dependence	0.000453	0.00124	CcSEcCtD
Bosentan—Asthenia—Acamprosate—alcohol dependence	0.000449	0.00123	CcSEcCtD
Bosentan—Back pain—Citalopram—alcohol dependence	0.000445	0.00121	CcSEcCtD
Bosentan—Pruritus—Acamprosate—alcohol dependence	0.000443	0.00121	CcSEcCtD
Bosentan—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000443	0.00229	CbGpPWpGaD
Bosentan—Muscle spasms—Citalopram—alcohol dependence	0.000442	0.00121	CcSEcCtD
Bosentan—EDNRB—GPCR downstream signaling—CHRM2—alcohol dependence	0.00044	0.00228	CbGpPWpGaD
Bosentan—Hypersensitivity—Naltrexone—alcohol dependence	0.000437	0.00119	CcSEcCtD
Bosentan—EDNRB—GPCR ligand binding—AVP—alcohol dependence	0.000435	0.00225	CbGpPWpGaD
Bosentan—CYP2C9—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000434	0.00225	CbGpPWpGaD
Bosentan—Vision blurred—Citalopram—alcohol dependence	0.000433	0.00118	CcSEcCtD
Bosentan—Tremor—Citalopram—alcohol dependence	0.000431	0.00118	CcSEcCtD
Bosentan—Diarrhoea—Acamprosate—alcohol dependence	0.000428	0.00117	CcSEcCtD
Bosentan—Anaemia—Citalopram—alcohol dependence	0.000425	0.00116	CcSEcCtD
Bosentan—Asthenia—Naltrexone—alcohol dependence	0.000425	0.00116	CcSEcCtD
Bosentan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000425	0.0022	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—CRHR1—alcohol dependence	0.000425	0.0022	CbGpPWpGaD
Bosentan—Angioedema—Citalopram—alcohol dependence	0.00042	0.00115	CcSEcCtD
Bosentan—CYP2C9—Biological oxidations—ADH4—alcohol dependence	0.000419	0.00217	CbGpPWpGaD
Bosentan—Pruritus—Naltrexone—alcohol dependence	0.000419	0.00114	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—OPRK1—alcohol dependence	0.000419	0.00217	CbGpPWpGaD
Bosentan—CYP3A4—Tryptophan metabolism—ALDH2—alcohol dependence	0.000417	0.00216	CbGpPWpGaD
Bosentan—CYP2C9—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000415	0.00215	CbGpPWpGaD
Bosentan—Dizziness—Acamprosate—alcohol dependence	0.000414	0.00113	CcSEcCtD
Bosentan—Vertigo—Citalopram—alcohol dependence	0.000413	0.00113	CcSEcCtD
Bosentan—Syncope—Citalopram—alcohol dependence	0.000412	0.00113	CcSEcCtD
Bosentan—Leukopenia—Citalopram—alcohol dependence	0.000412	0.00112	CcSEcCtD
Bosentan—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000409	0.00212	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—AVP—alcohol dependence	0.000409	0.00212	CbGpPWpGaD
Bosentan—Palpitations—Citalopram—alcohol dependence	0.000406	0.00111	CcSEcCtD
Bosentan—Diarrhoea—Naltrexone—alcohol dependence	0.000405	0.00111	CcSEcCtD
Bosentan—EDNRA—Peptide ligand-binding receptors—POMC—alcohol dependence	0.000405	0.0021	CbGpPWpGaD
Bosentan—Loss of consciousness—Citalopram—alcohol dependence	0.000404	0.0011	CcSEcCtD
Bosentan—EDNRB—GPCR downstream signaling—OPRM1—alcohol dependence	0.000404	0.00209	CbGpPWpGaD
Bosentan—CYP2C9—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000404	0.00209	CbGpPWpGaD
Bosentan—Cough—Citalopram—alcohol dependence	0.000401	0.0011	CcSEcCtD
Bosentan—EDNRB—Signaling by GPCR—CHRM2—alcohol dependence	0.000399	0.00207	CbGpPWpGaD
Bosentan—Vomiting—Acamprosate—alcohol dependence	0.000398	0.00109	CcSEcCtD
Bosentan—EDNRA—GPCRs, Class A Rhodopsin-like—HTR2A—alcohol dependence	0.000397	0.00205	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—DRD4—alcohol dependence	0.000397	0.00205	CbGpPWpGaD
Bosentan—Rash—Acamprosate—alcohol dependence	0.000395	0.00108	CcSEcCtD
Bosentan—Dermatitis—Acamprosate—alcohol dependence	0.000394	0.00108	CcSEcCtD
Bosentan—CYP3A4—Biological oxidations—ADH6—alcohol dependence	0.000393	0.00203	CbGpPWpGaD
Bosentan—Headache—Acamprosate—alcohol dependence	0.000392	0.00107	CcSEcCtD
Bosentan—Dizziness—Naltrexone—alcohol dependence	0.000392	0.00107	CcSEcCtD
Bosentan—Arthralgia—Citalopram—alcohol dependence	0.000392	0.00107	CcSEcCtD
Bosentan—Chest pain—Citalopram—alcohol dependence	0.000392	0.00107	CcSEcCtD
Bosentan—Anxiety—Citalopram—alcohol dependence	0.00039	0.00106	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000389	0.00106	CcSEcCtD
Bosentan—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000388	0.00201	CbGpPWpGaD
Bosentan—Discomfort—Citalopram—alcohol dependence	0.000387	0.00106	CcSEcCtD
Bosentan—Dry mouth—Citalopram—alcohol dependence	0.000383	0.00105	CcSEcCtD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	0.000379	0.00196	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—CNR1—alcohol dependence	0.000379	0.00196	CbGpPWpGaD
Bosentan—Vomiting—Naltrexone—alcohol dependence	0.000377	0.00103	CcSEcCtD
Bosentan—EDNRA—GPCR downstream signaling—OPRD1—alcohol dependence	0.000376	0.00194	CbGpPWpGaD
Bosentan—Oedema—Citalopram—alcohol dependence	0.000375	0.00102	CcSEcCtD
Bosentan—Anaphylactic shock—Citalopram—alcohol dependence	0.000375	0.00102	CcSEcCtD
Bosentan—Rash—Naltrexone—alcohol dependence	0.000374	0.00102	CcSEcCtD
Bosentan—Dermatitis—Naltrexone—alcohol dependence	0.000373	0.00102	CcSEcCtD
Bosentan—Infection—Citalopram—alcohol dependence	0.000373	0.00102	CcSEcCtD
Bosentan—Nausea—Acamprosate—alcohol dependence	0.000372	0.00102	CcSEcCtD
Bosentan—EDNRB—GPCR downstream signaling—NPY—alcohol dependence	0.000372	0.00192	CbGpPWpGaD
Bosentan—Headache—Naltrexone—alcohol dependence	0.000371	0.00101	CcSEcCtD
Bosentan—EDNRA—GPCR ligand binding—DRD2—alcohol dependence	0.00037	0.00191	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—HTR7—alcohol dependence	0.00037	0.00191	CbGpPWpGaD
Bosentan—Shock—Citalopram—alcohol dependence	0.000369	0.00101	CcSEcCtD
Bosentan—Nervous system disorder—Citalopram—alcohol dependence	0.000368	0.001	CcSEcCtD
Bosentan—Thrombocytopenia—Citalopram—alcohol dependence	0.000368	0.001	CcSEcCtD
Bosentan—EDNRB—Signaling by GPCR—OPRM1—alcohol dependence	0.000367	0.0019	CbGpPWpGaD
Bosentan—Tachycardia—Citalopram—alcohol dependence	0.000366	0.001	CcSEcCtD
Bosentan—Skin disorder—Citalopram—alcohol dependence	0.000365	0.000995	CcSEcCtD
Bosentan—Hyperhidrosis—Citalopram—alcohol dependence	0.000363	0.00099	CcSEcCtD
Bosentan—EDNRB—GPCR ligand binding—HTR2A—alcohol dependence	0.000362	0.00187	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—PDYN—alcohol dependence	0.00036	0.00186	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—HTR1B—alcohol dependence	0.000359	0.00186	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—CRH—alcohol dependence	0.000359	0.00186	CbGpPWpGaD
Bosentan—Anorexia—Citalopram—alcohol dependence	0.000358	0.000977	CcSEcCtD
Bosentan—CYP2C9—Biological oxidations—ADH7—alcohol dependence	0.000357	0.00185	CbGpPWpGaD
Bosentan—Nausea—Naltrexone—alcohol dependence	0.000352	0.00096	CcSEcCtD
Bosentan—Hypotension—Citalopram—alcohol dependence	0.000351	0.000957	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000342	0.000933	CcSEcCtD
Bosentan—CYP2C9—Biological oxidations—GGT2—alcohol dependence	0.000342	0.00177	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—OPRD1—alcohol dependence	0.000341	0.00177	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	0.00034	0.00176	CbGpPWpGaD
Bosentan—Insomnia—Citalopram—alcohol dependence	0.00034	0.000927	CcSEcCtD
Bosentan—EDNRB—Signaling by GPCR—NPY—alcohol dependence	0.000337	0.00175	CbGpPWpGaD
Bosentan—Paraesthesia—Citalopram—alcohol dependence	0.000337	0.00092	CcSEcCtD
Bosentan—EDNRA—GPCR downstream signaling—CRHR1—alcohol dependence	0.000335	0.00173	CbGpPWpGaD
Bosentan—Dyspnoea—Citalopram—alcohol dependence	0.000335	0.000913	CcSEcCtD
Bosentan—Somnolence—Citalopram—alcohol dependence	0.000334	0.000911	CcSEcCtD
Bosentan—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000334	0.00173	CbGpPWpGaD
Bosentan—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000332	0.00172	CbGpPWpGaD
Bosentan—Dyspepsia—Citalopram—alcohol dependence	0.00033	0.000902	CcSEcCtD
Bosentan—EDNRA—Signaling by GPCR—PDYN—alcohol dependence	0.000327	0.00169	CbGpPWpGaD
Bosentan—Decreased appetite—Citalopram—alcohol dependence	0.000326	0.000891	CcSEcCtD
Bosentan—EDNRB—Signaling by GPCR—HTR1B—alcohol dependence	0.000326	0.00169	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—CRH—alcohol dependence	0.000326	0.00169	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	0.000325	0.00168	CbGpPWpGaD
Bosentan—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000324	0.000884	CcSEcCtD
Bosentan—Fatigue—Citalopram—alcohol dependence	0.000324	0.000883	CcSEcCtD
Bosentan—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000322	0.00167	CbGpPWpGaD
Bosentan—Constipation—Citalopram—alcohol dependence	0.000321	0.000876	CcSEcCtD
Bosentan—Pain—Citalopram—alcohol dependence	0.000321	0.000876	CcSEcCtD
Bosentan—EDNRA—GPCR downstream signaling—CHRM2—alcohol dependence	0.000315	0.00163	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—DRD4—alcohol dependence	0.000313	0.00162	CbGpPWpGaD
Bosentan—CYP2C9—Biological oxidations—ADH1B—alcohol dependence	0.000313	0.00162	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—AVP—alcohol dependence	0.000311	0.00161	CbGpPWpGaD
Bosentan—Gastrointestinal pain—Citalopram—alcohol dependence	0.000307	0.000838	CcSEcCtD
Bosentan—ABCB11—Metabolism—ADH6—alcohol dependence	0.000305	0.00158	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—CRHR1—alcohol dependence	0.000304	0.00157	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—OPRK1—alcohol dependence	0.0003	0.00155	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—CNR1—alcohol dependence	0.000299	0.00155	CbGpPWpGaD
Bosentan—Urticaria—Citalopram—alcohol dependence	0.000298	0.000814	CcSEcCtD
Bosentan—Abdominal pain—Citalopram—alcohol dependence	0.000297	0.00081	CcSEcCtD
Bosentan—Body temperature increased—Citalopram—alcohol dependence	0.000297	0.00081	CcSEcCtD
Bosentan—EDNRB—GPCR downstream signaling—DRD2—alcohol dependence	0.000292	0.00151	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—HTR7—alcohol dependence	0.000292	0.00151	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—OPRM1—alcohol dependence	0.000289	0.0015	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—POMC—alcohol dependence	0.000289	0.0015	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—CHRM2—alcohol dependence	0.000286	0.00148	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—DRD4—alcohol dependence	0.000285	0.00147	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—OPRD1—alcohol dependence	0.000282	0.00146	CbGpPWpGaD
Bosentan—Hypersensitivity—Citalopram—alcohol dependence	0.000277	0.000755	CcSEcCtD
Bosentan—CYP3A4—Biological oxidations—ADH4—alcohol dependence	0.000277	0.00143	CbGpPWpGaD
Bosentan—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000273	0.00142	CbGpPWpGaD
Bosentan—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000273	0.00141	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—CNR1—alcohol dependence	0.000272	0.00141	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	0.000272	0.00141	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PDYN—alcohol dependence	0.00027	0.0014	CbGpPWpGaD
Bosentan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.00027	0.0014	CbGpPWpGaD
Bosentan—Asthenia—Citalopram—alcohol dependence	0.000269	0.000735	CcSEcCtD
Bosentan—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000266	0.00138	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—NPY—alcohol dependence	0.000266	0.00138	CbGpPWpGaD
Bosentan—Pruritus—Citalopram—alcohol dependence	0.000266	0.000725	CcSEcCtD
Bosentan—EDNRB—Signaling by GPCR—HTR7—alcohol dependence	0.000265	0.00137	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—DRD2—alcohol dependence	0.000265	0.00137	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—OPRM1—alcohol dependence	0.000262	0.00136	CbGpPWpGaD
Bosentan—CYP2C9—Biological oxidations—MAOB—alcohol dependence	0.000259	0.00134	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—HTR2A—alcohol dependence	0.000259	0.00134	CbGpPWpGaD
Bosentan—Diarrhoea—Citalopram—alcohol dependence	0.000257	0.000701	CcSEcCtD
Bosentan—EDNRA—GPCR downstream signaling—HTR1B—alcohol dependence	0.000257	0.00133	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—CRH—alcohol dependence	0.000257	0.00133	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ADH1A—alcohol dependence	0.000253	0.00131	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—WASF2—alcohol dependence	0.000251	0.0013	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CRHR1—alcohol dependence	0.000251	0.0013	CbGpPWpGaD
Bosentan—Dizziness—Citalopram—alcohol dependence	0.000248	0.000677	CcSEcCtD
Bosentan—EDNRB—GPCR downstream signaling—AVP—alcohol dependence	0.000246	0.00127	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—NPY—alcohol dependence	0.000242	0.00125	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—WASF1—alcohol dependence	0.000241	0.00125	CbGpPWpGaD
Bosentan—Vomiting—Citalopram—alcohol dependence	0.000239	0.000651	CcSEcCtD
Bosentan—Rash—Citalopram—alcohol dependence	0.000237	0.000646	CcSEcCtD
Bosentan—Dermatitis—Citalopram—alcohol dependence	0.000236	0.000645	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—CHRM2—alcohol dependence	0.000236	0.00122	CbGpPWpGaD
Bosentan—Headache—Citalopram—alcohol dependence	0.000235	0.000642	CcSEcCtD
Bosentan—CYP3A4—Biological oxidations—ADH7—alcohol dependence	0.000235	0.00122	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—HTR1B—alcohol dependence	0.000233	0.00121	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—CRH—alcohol dependence	0.000233	0.00121	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—GGT2—alcohol dependence	0.000225	0.00117	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—DRD4—alcohol dependence	0.000224	0.00116	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—AVP—alcohol dependence	0.000223	0.00116	CbGpPWpGaD
Bosentan—Nausea—Citalopram—alcohol dependence	0.000223	0.000609	CcSEcCtD
Bosentan—CYP2C9—Biological oxidations—ALDH2—alcohol dependence	0.00022	0.00114	CbGpPWpGaD
Bosentan—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000219	0.00113	CbGpPWpGaD
Bosentan—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000219	0.00113	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—OPRM1—alcohol dependence	0.000217	0.00112	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ADH4—alcohol dependence	0.000215	0.00111	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—CNR1—alcohol dependence	0.000214	0.00111	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—DRD2—alcohol dependence	0.000209	0.00108	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—HTR7—alcohol dependence	0.000209	0.00108	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—POMC—alcohol dependence	0.000207	0.00107	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	0.000206	0.00107	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—HTR2A—alcohol dependence	0.000204	0.00106	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—DRD4—alcohol dependence	0.000204	0.00105	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—OPRD1—alcohol dependence	0.000202	0.00104	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—NPY—alcohol dependence	0.000199	0.00103	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—CNR1—alcohol dependence	0.000194	0.00101	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PDYN—alcohol dependence	0.000193	0.001	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—HTR1B—alcohol dependence	0.000192	0.000996	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CRH—alcohol dependence	0.000192	0.000996	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—DRD2—alcohol dependence	0.00019	0.000982	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—HTR7—alcohol dependence	0.00019	0.000982	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	0.000186	0.000963	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—HTR2A—alcohol dependence	0.000186	0.000961	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ADH7—alcohol dependence	0.000183	0.000946	CbGpPWpGaD
Bosentan—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.00018	0.000931	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CRHR1—alcohol dependence	0.00018	0.00093	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—WASF2—alcohol dependence	0.00018	0.00093	CbGpPWpGaD
Bosentan—CYP2C9—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000178	0.000919	CbGpPWpGaD
Bosentan—CYP2C9—Biological oxidations—CYP2E1—alcohol dependence	0.000176	0.000912	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—AVP—alcohol dependence	0.000176	0.000911	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GGT2—alcohol dependence	0.000175	0.000906	CbGpPWpGaD
Bosentan—CYP2C9—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000174	0.000899	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—WASF1—alcohol dependence	0.000172	0.000891	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—MAOB—alcohol dependence	0.000171	0.000885	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CHRM2—alcohol dependence	0.000169	0.000874	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—DRD4—alcohol dependence	0.000168	0.00087	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—POMC—alcohol dependence	0.000163	0.000845	CbGpPWpGaD
Bosentan—CYP2C9—Biological oxidations—GGT1—alcohol dependence	0.000162	0.000837	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CNR1—alcohol dependence	0.000161	0.000831	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ADH1B—alcohol dependence	0.00016	0.000829	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—AVP—alcohol dependence	0.00016	0.000827	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—DRD2—alcohol dependence	0.000157	0.000811	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—HTR7—alcohol dependence	0.000157	0.000811	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—OPRM1—alcohol dependence	0.000155	0.000803	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—POMC—alcohol dependence	0.000148	0.000768	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—HTR2A—alcohol dependence	0.000146	0.000758	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	0.000145	0.000752	CbGpPWpGaD
Bosentan—CYP2C9—Biological oxidations—MAOA—alcohol dependence	0.000145	0.00075	CbGpPWpGaD
Bosentan—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000144	0.000748	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—NPY—alcohol dependence	0.000143	0.000739	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—HTR1B—alcohol dependence	0.000138	0.000713	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CRH—alcohol dependence	0.000138	0.000713	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—HTR2A—alcohol dependence	0.000133	0.000688	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—MAOB—alcohol dependence	0.000133	0.000687	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—AVP—alcohol dependence	0.000132	0.000682	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—DRD4—alcohol dependence	0.00012	0.000623	CbGpPWpGaD
Bosentan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000117	0.000606	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—POMC—alcohol dependence	0.000117	0.000605	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	0.000116	0.000601	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CNR1—alcohol dependence	0.000115	0.000595	CbGpPWpGaD
Bosentan—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000115	0.000593	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ALDH2—alcohol dependence	0.000113	0.000584	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—HTR7—alcohol dependence	0.000112	0.00058	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—DRD2—alcohol dependence	0.000112	0.00058	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—HTR2A—alcohol dependence	0.00011	0.000568	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	0.000108	0.000562	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—GGT1—alcohol dependence	0.000107	0.000552	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—POMC—alcohol dependence	0.000106	0.000549	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ADH6—alcohol dependence	0.000102	0.000527	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GOT2—alcohol dependence	9.59e-05	0.000497	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—MAOA—alcohol dependence	9.56e-05	0.000495	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—AVP—alcohol dependence	9.43e-05	0.000488	CbGpPWpGaD
Bosentan—CYP2C9—Biological oxidations—POMC—alcohol dependence	9.43e-05	0.000488	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CYP2E1—alcohol dependence	9.02e-05	0.000467	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—POMC—alcohol dependence	8.76e-05	0.000454	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ADH1A—alcohol dependence	8.43e-05	0.000437	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GGT1—alcohol dependence	8.28e-05	0.000429	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GOT1—alcohol dependence	8.28e-05	0.000429	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—HTR2A—alcohol dependence	7.85e-05	0.000406	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—MAOA—alcohol dependence	7.42e-05	0.000384	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	7.2e-05	0.000373	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ADH4—alcohol dependence	7.17e-05	0.000371	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ADH6—alcohol dependence	6.71e-05	0.000348	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—POMC—alcohol dependence	6.27e-05	0.000325	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—POMC—alcohol dependence	6.22e-05	0.000322	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	6.21e-05	0.000321	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ADH7—alcohol dependence	6.1e-05	0.000316	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GGT2—alcohol dependence	5.85e-05	0.000303	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—EP300—alcohol dependence	5.81e-05	0.000301	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ADH1A—alcohol dependence	5.56e-05	0.000288	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ADH1B—alcohol dependence	5.35e-05	0.000277	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—POMC—alcohol dependence	4.83e-05	0.00025	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ADH4—alcohol dependence	4.73e-05	0.000245	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—MAOB—alcohol dependence	4.43e-05	0.000229	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—EP300—alcohol dependence	4.16e-05	0.000215	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ADH7—alcohol dependence	4.02e-05	0.000208	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GGT2—alcohol dependence	3.86e-05	0.0002	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ALDH2—alcohol dependence	3.77e-05	0.000195	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	3.62e-05	0.000188	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ADH1B—alcohol dependence	3.53e-05	0.000183	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—EP300—alcohol dependence	3.21e-05	0.000166	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GOT2—alcohol dependence	3.2e-05	0.000166	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CYP2E1—alcohol dependence	3.01e-05	0.000156	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—MAOB—alcohol dependence	2.92e-05	0.000151	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GOT1—alcohol dependence	2.77e-05	0.000143	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GGT1—alcohol dependence	2.77e-05	0.000143	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ALDH2—alcohol dependence	2.48e-05	0.000129	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—MAOA—alcohol dependence	2.48e-05	0.000128	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	2.4e-05	0.000124	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GOT2—alcohol dependence	2.11e-05	0.000109	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CYP2E1—alcohol dependence	1.99e-05	0.000103	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GGT1—alcohol dependence	1.82e-05	9.44e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GOT1—alcohol dependence	1.82e-05	9.44e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—MAOA—alcohol dependence	1.63e-05	8.46e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—POMC—alcohol dependence	1.61e-05	8.35e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—EP300—alcohol dependence	1.07e-05	5.54e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—POMC—alcohol dependence	1.06e-05	5.51e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—EP300—alcohol dependence	7.06e-06	3.65e-05	CbGpPWpGaD
